Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand ... - Reuters PDF Print
ReutersThe report also finds that although surveyed nephrologists have an overall conservative attitude towards biosimilar use, they are not completely opposed to

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.